Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Bellicum Pharma Comm (BLCM)

7.03 0.36 (5.4%)

02-23 16:00

Open:

7.25

Pre. Close:

6.67

High:

7.5348

Low:

6.79

Volume:

1,272,724

Market Cap:

234M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

7.539 - 7.567

7.567 - 7.59

Low:

6.72 - 6.753

6.753 - 6.779

Close:

6.98 - 7.031

7.031 - 7.073

Technical analysis  (as of: 2018-02-23 4:40:09 PM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 10.28     One year: 12.01

Support:

Support1: 6.46    Support2: 5.02

Resistance:

Resistance1: 8.80    Resistance2: 10.28

Pivot:

6.11

Moving Averages:

MA(5): 6.76     MA(20): 6.43

MA(100): 8.95     MA(250): 10.61

MACD:

MACD(12,26): -0.36     Signal(12,26,9): -0.57

%K %D:

%K(14,3): 71.73     %D(3): 62.89

RSI:

RSI(14): 51.47

52-Week:

High: 15.55  Low: 5.02  Change(%): -44.6

Average Vol(K):

3-Month: 80140  10-Days 89218

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
BLCM has closed below upper band by 4.4%. Bollinger Bands are 1.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Sat, 10 Feb 2018 14:03:45 GMT
Is Bellicum Pharmaceuticals, Inc. a Buy Now?

Wed, 21 Feb 2018 12:00:00 GMT
Bellicum Pharmaceuticals Appoints Edmund P. Harrigan, MD to its Board of Directors

Thu, 25 Jan 2018 15:22:30 GMT
Will 2018 Be Bellicum Pharmaceuticals, Inc.'s Best Year Yet?

Tue, 20 Feb 2018 22:41:15 GMT
IMPORTANT INVESTOR REMINDER FOR ALL OWNERS OF BELLICUM PHARMACEUTICALS, INC ...

Tue, 30 Jan 2018 21:45:00 GMT
Bellicum Pharmaceuticals Announces Clinical Hold on BPX-501 Clinical Trials in ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

33.26

Shares Float (M)

32.89

% Held by Insiders

% Held by Institutions

56.90

Shares Short (K)

4614

Shares Short Prior Month (K)

4090

Stock Financials

EPS

-2.990

EPS Est. Current Year

-3.020

EPS Est. Next Year

-2.950

EPS Est. Next Quarter

-0.740

Forward EPS

-2.933

Book Value (p.s.)

2.130

PEG Ratio

Profit Margin

Operating Margin

-26105.97

Return on Assets (ttm)

-60.5

Return on Equity (ttm)

-81.2

Qtrly Rev. Growth

10.5

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-2.503

Qtrly Earnings Growth

Operating Cash Flow (M)

-74.65

Levered Free Cash Flow (M)

-48.35

atoplab.com

Valuation

P/E

-2.35

P/E Growth Ratio

0.05

P/BV

3.30

P/S

23381780480.00

P/CF

-3.13

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.